Preliminary Agenda for the 2023 Cannabinoids in Clinical Practice Conference
Please note, speaker presentation order may change within the same session.
This program has been accredited by the Royal College of Physicians & Surgeons of Canada for 10.5 Section 1 hours. Family physicians who have actively participated in accredited Royal College of Physicians and Surgeons of Canada Section 1 activities are eligible to earn up to a maximum of 50 certified credits per five year cycle; any additional credits are eligible as non-certified credits.
Please note: Learning from poster presentations may be claimed as a scanning activity under Section 2. You may claim 0.5 credits per poster with a documented learning outcome: https://www.royalcollege.ca/rcsite/cpd/moc-program/moc-framework-e
| DAY 1 : Thursday June 22, 2023 | ||
| Breakfast | ||
| Introductions and CCIC Update | Matthew Hill, CCIC Executive Director | |
| SESSION 1: Basics and Biology of Cannabinoids and the Endocannabinoid System | ||
| Cannabinoids 101 | Cecilia Hillard, PhD | |
| Update on CBD Research | Ruth Ross, PhD | |
| Health and Coffee Break | ||
| The complex pharmacology of cannabinoids and terpenoids beyond delta9-tetrahydrocannabinol and cannabidiol. | Robert Laprairie, PhD | |
| Trainee Research Award Presentations | ||
| TBD | TBD | |
| TBD | TBD | |
| Lunch | ||
| SESSION 2: Non-Medical Cannabis Use and Health Impacts | ||
| Influences of Genetic Variants on Acute Responses to Smoked Cannabis | Justin Matheson, PhD | |
| Navigating the Weeds: Chronic and Acute Effects of High-Potency Concentrates vs. Flower on Cognition | Carrie Cuttler, PhD | |
| Predicting Problematic Cannabis Use in a Young Adult Population | Kim Hellemans, PhD | |
| Poster Session | ||
| Trainee Research Award Presentation | ||
| TBD | TBD | |
| Panel Discussion: Managing cannabis in patients with mental illness & patients with CUD | ||
| AGM | ||
| Networking Social | ||
| DAY 1 CLOSES | ||
| Day 2: Friday June 23, 2023 | ||
| Breakfast | ||
| SESSION 3: Medical Cannabis and Therapeutic Targets | ||
| A novel treatment approach for CUD | Margaret Haney, PhD | |
| Epilepsy & Cannabis | Elizabeth Thiele, MD, PhD | |
| PTSD & Cannabis | Matthew Hill, PhD | |
| Health and Coffee Break | ||
| Updated Clinical Overview on Pain | Hance Clarke, MD, PhD, FRCPC | |
| Panel Discussion: Focus on Pain Conditions | ||
| Lunch | ||
| SESSION 4: Harm Reduction and Public Health Implications of Cannabis Legalization | ||
| Should cannabis THC standard units be established in Canada? Considerations for consumers, industry, and regulators. | David Hammond, PhD | |
| Health Canada Update on the Non-Therapeutic Research on Cannabis Framework | Sophie-Anne Lamour | |
| Cannabis and Problematic Substance Use: New Finding on Substitution and Harm Reduction From High Risk Populations | Zachary Walsh, PhD | |
| Poster Session | ||
| Trainee Research Award Presentation | ||
| TBD | TBD | |
| Health Canada Update: How has Cannabis Legalization Impacted Public Health? | George Mammen, PhD | |
| Cannabis Use During the COVID-19 Pandemic | Sameer Imtiaz, PhD | |
| CLOSING REMARKS | ||
| CONGRESS CLOSES |